-
Posted by
Two Blokes May 15 -
Filed in
General
-
#TwoBlokesTrading
-
16 views
Trump's new ‘Most-Favored-Nation' drug pricing order just rewrote the rules of American pharma economics - and investors haven't processed the aftershock yet. On a day when the S&P closed positive - and tech and energy sectors rallied 1.5%-2% on easing U.S.-China tensions and cooling inflation - pharma and biotech ETFs crashed >2%.
